Alife Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 18

Alife General Information

Description

Developer of an artificial intelligence-based health technology designed to help people have healthy children. The company uses advancements in deep learning and software development technologies to help doctors select the healthiest embryos, enabling patients and future parents to improve their chances of a healthy pregnancy.

Contact Information

Website
www.alifehealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3717 Buchanan Street
  • Suite 400
  • San Francisco, CA 94123
  • United States
+1 (707)
Primary Industry
Decision/Risk Analysis
Other Industries
Enterprise Systems (Healthcare)
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, FemTech, HealthTech
Corporate Office
  • 3717 Buchanan Street
  • Suite 400
  • San Francisco, CA 94123
  • United States
+1 (707)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alife Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 01-Sep-2024 Completed Generating Revenue
4. Accelerator/Incubator 10-May-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Mar-2022 Completed Generating Revenue
2. Seed Round 12-Apr-2021 $9.5M $9.5M Completed Generating Revenue
1. Grant 16-Apr-2020 $75K Completed Generating Revenue
To view Alife’s complete valuation and funding history, request access »

Alife Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed-1
Seed 2,828,437 $0.000100 $2.83 $2.83 1x $2.83 13.96%
To view Alife’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Alife Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence-based health technology designed to help people have healthy children. The compa
Decision/Risk Analysis
San Francisco, CA
44 As of 2023

Tel Aviv, Israel
 

Westborough, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alife Competitors (3)

One of Alife’s 3 competitors is AIVF, a Venture Capital-Backed company based in Tel Aviv, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AIVF Venture Capital-Backed Tel Aviv, Israel
Ovia Health Venture Capital-Backed Westborough, MA
Kindara Formerly VC-backed Boulder, CO
You’re viewing 3 of 3 competitors. Get the full list »

Alife Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Alife Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026047580-A1 Methods for family planning using predictive models Pending 28-Aug-2024
US-20240347182-A1 Methods for optimizing clinical embryology workload using artificial intelligence Pending 23-Mar-2023
WO-2024197195-A2 Methods for optimizing clinical embryology workload using artificial intelligence Inactive 23-Mar-2023
WO-2024197195-A3 Methods for optimizing clinical embryology workload using artificial intelligence Inactive 23-Mar-2023
AU-2022289837-A1 Machine learning for optimizing ovarian stimulation Inactive 10-Jun-2021 G16H20/10
To view Alife’s complete patent history, request access »

Alife Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alife Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Freya Ventures Venture Capital Minority
Angel (individual) Minority
Farvatn Venture Venture Capital Minority
Freesolo Capital Venture Capital Minority
Maveron Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Alife FAQs

  • When was Alife founded?

    Alife was founded in 2020.

  • Where is Alife headquartered?

    Alife is headquartered in San Francisco, CA.

  • What is the size of Alife?

    Alife has 44 total employees.

  • What industry is Alife in?

    Alife’s primary industry is Decision/Risk Analysis.

  • Is Alife a private or public company?

    Alife is a Private company.

  • What is Alife’s current revenue?

    The current revenue for Alife is .

  • How much funding has Alife raised over time?

    Alife has raised $31.5M.

  • Who are Alife’s investors?

    Freya Ventures, , Farvatn Venture, Freesolo Capital, and Maveron are 5 of 18 investors who have invested in Alife.

  • Who are Alife’s competitors?

    AIVF, Ovia Health, and Kindara are competitors of Alife.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process